Details of Drug-Drug Interaction
| Drug General Information (ID: DDIA71UDIN) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Rifabutin | Drug Info | Cabotegravir | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Antibiotics | Antiviral Agents | |||||||
| Structure | |||||||||
| Mechanism of Rifabutin-Cabotegravir Interaction (Severity Level: Major) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Increased metabolism (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Rifabutin | Cabotegravir | |||||||
| Mechanism | Decrease the plasma concentrations of cabotegravir | Cabotegravir | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Pharmacokinetics | ||||||||
| Factor Description | Alters the metabolism of the drug, leading to changes in the plasma concentration of the drug and affecting the pharmacological effects. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | If cabotegravir is prescribed in combination with rilpivirine, concomitant use of rifabutin is considered contraindicated by the manufacturer. | ||||||||
